...
首页> 外文期刊>Drug delivery and translational research >Release pattern of dexamethasone after administration through an implant-mediated drug delivery device with an active plunger of super absorbent polymer
【24h】

Release pattern of dexamethasone after administration through an implant-mediated drug delivery device with an active plunger of super absorbent polymer

机译:通过植入物介导的药物递送装置在给药后释放地塞米松的模式,其具有超吸收性聚合物的有源柱塞

获取原文
获取原文并翻译 | 示例

摘要

The implant-mediated drug delivery system (IMDDS) is a novel, innovative device that allows drug delivery through bone marrow. The purpose of this study was to investigate the effect of an active plunger component made of super absorbent polymer (SAP) on the plasma concentration of dexamethasone released from the IMDDS. The IMDDSs were installed in a total of 18 rabbits. After complete healing, dexamethasone was loaded with the SAP active plunger and with water to cause expansion in the test group (n = 9), while only the drug was loaded in the control group, as per the original protocol (n = 9). The release patterns of each group were monitored for 2 weeks by measuring the plasma concentration of the drug. Both groups showed sustained release of drug. However, the test groups showed more rapid increase in plasma concentration and higher area under the curve (AUC) throughout the observation period. The incorporation of a SAP active plunger component in the IMDDS resulted in an increase in initial release of drug and higher bioavailability within the observation period of 2 weeks after dexamethasone administration.
机译:植入介导的药物递送系统(IMDDS)是一种新型的创新装置,可通过骨髓递送。本研究的目的是研究由超吸收性聚合物(SAP)制成的有源柱塞组分对从IMDDS释放的地塞米松的血浆浓度的影响。 IMDDS总共安装了18只兔子。在完全愈合后,用SAP活性柱塞和水加载地塞米松,导致试验组(n = 9)中的膨胀,同时仅根据原始方案(n = 9),仅在对照组中加载药物。通过测量药物的血浆浓度来监测每组的释放模式2周。两组均显示出持续释放的药物。然而,在整个观察期间,测试组显示血浆浓度和曲线(AUC)下的血浆浓度和更高面积的增加。在IMDDS中掺入SAP活性柱塞组分导致在地塞米松给药后2周的观察期内初始释放药物和更高的生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号